Transplant Surgery Informed Consent: 8 Key Areas Patients Must Understand Before Signing

Informed consent for solid organ transplantation (kidney, liver, heart, lung, pancreas, intestine) or vascularized composite allotransplantation (VCA) is a comprehensive, multi-session process ensuring autonomous, informed decision-making.

Eight Mandatory Consent Elements

1. Medical Condition and Transplant Necessity:
   • Diagnosis, disease natural history, why transplant is the optimal therapy vs. alternatives (dialysis, VAD, medical management).
   • Organ-specific severity scores (MELD-Na, LAS, KDPI, EPTS).
2. Surgical Procedure:
   • Detailed operative steps, incision, vascular anastomoses, biliary/ureteral/enteric reconstruction.
   • Techniques: deceased vs. living donor; split liver, domino, en bloc; robotic/minimally invasive options.
   • Risks: Bleeding, thrombosis, biliary/urinary leak, vascular complication, primary non-function (PNF), delayed graft function (DGF).
3. Donor Selection and Matching:
   • Deceased: ABO, HLA, size, age, KDPI/Donor Risk Index, geographic allocation (OPTN/UNOS policy).
   • Living: Donor evaluation (medical, psychosocial, financial, informed consent), paired exchange, non-directed donation.
   • Donor risks: Nephrectomy (living kidney) — 0.03% mortality, long-term ESRD risk slightly elevated.
4. Immunosuppressive Therapy (Lifelong):
   • Induction (basiliximab, thymoglobulin, alemtuzumab) + Maintenance (tacrolimus/MMF/prednisone ± mTORi, belatacept).
   • Side effects: Infection (opportunistic), nephrotoxicity (CNI), neurotoxicity, diabetes (PTDM), hypertension, dyslipidemia, bone loss, malignancy (skin, PTLD), tremor, GI.
   • Adherence is non-negotiable; nonadherence → rejection → graft loss.
5. Post-Transplant Care:
   • Intensive early follow-up (labs 2–3x/week → monthly → quarterly).
   • Protocol biopsies (kidney, liver, heart).
   • Surveillance: Cancer screening, CVD risk, bone density, vaccinations (inactivated only).
   • Lifestyle: Diet (low sodium, renal), exercise, sun protection, no smoking, alcohol moderation, travel precautions.
6. Risks and Outcomes:
   • Rejection: Hyperacute (rare), Acute Cellular (TCMR), Antibody-Mediated (ABMR), Chronic.
   • Infection: Bacterial, viral (CMV, BK, EBV), fungal, TB.
   • Malignancy: Skin (SCC/BCC), PTLD, Kaposi, solid tumors.
   • Survival Data: 1-yr/5-yr/10-yr graft and patient survival (SRTR/OPTN reports, center-specific).
7. Alternative Treatments:
   • Dialysis (hemodialysis, peritoneal), VAD (destination therapy), medical management, palliative care.
   • Risks/benefits of each vs. transplant.
8. Right to Withdraw Consent:
   • Voluntary at any time before anesthesia induction.
   • No coercion; decision respected without penalty to future care.

Consent is a process, not a form. Ongoing dialogue ensures alignment with patient values and evolving clinical reality.